Lamivudine prophylaxis in liver transplantation for hepatitis B in Asians

Transplant Proc. 1999 Feb-Mar;31(1-2):535-6. doi: 10.1016/s0041-1345(98)01542-5.

Authors

C M Lo¹, S T Fan, C L Lai, C L Liu, M F Yuen, I O Ng, J Wong

Affiliation

¹ Department of Surgery, University of Hong Kong Medical Center, Queen Mary Hospital, China.

PMID: 10083224
DOI: 10.1016/s0041-1345(98)01542-5

No abstract available

MeSH terms

Antiviral Agents / therapeutic use*
Asia
DNA, Viral / blood
Follow-Up Studies
Hepatic Encephalopathy / surgery
Hepatitis B / prevention & control*
Hepatitis B / surgery*
Hepatitis B Surface Antigens / analysis
Hepatitis B Surface Antigens / blood
Hepatitis B e Antigens / blood
Hepatitis B, Chronic / mortality
Hepatitis B, Chronic / surgery
Hong Kong
Humans
Lamivudine / therapeutic use*
Liver Transplantation* / mortality
Recurrence
Survival Rate
Time Factors

Substances

Antiviral Agents
DNA, Viral
Hepatitis B Surface Antigens
Hepatitis B e Antigens
Lamivudine